Is Long COVID Syndrome a Transient Mitochondriopathy Newly Discovered: Implications of CPET

Abstract

The new outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has an impact worldwide, primarily as a medical emergency. Even that the total constellation is considered as a pandemic of acute respiratory disease, coronavirus disease 2019 (COVID-19) gives rise to dysfunction in multiple organs (e.g., brain, lungs, heart, muscles) that impairs cardiopulmonary (CP) function. Parallel to the CP consequences of COVID-19 is a significant reduction in physical activity. Cardiopulmonary exercise testing (CPET) is daily used in clinical practice to define prognosis, provide risk stratification and treatment strategy. As such, the significance of CPET is crucial concerning clinical assessments of COVID-19 patients. Furthermore, new studies aim at understanding the effects of SARS-CoV-2 infection in long term. Multiple studies have investigated the cardiopulmonary function and impairment of exercise endurance in such patients, as well as a possible prolonged physical impairment. With this review, we summarize the COVID-19-associated pathophysiology for the Long COVID (LC) syndrome as well as the importance of performing CPET.

Mitochondriale Myopathien – Therapiemöglichkeiten durch Sport und Bewegung

“…Pathologisch veränderte Mitochondrien können dagegen sowohl bei genetisch bedingten Mitochondriopathien als auch sekundär bei erworbenen Muskelerkrankungen auftreten, z. B. bei Myositis oder Long Covid 8 , 9 . Die mitochondriale Funktion wird von 2 Genomen kontrolliert: das mitochondriale Genom (mtDNA) und das Kerngenom (nDNA).…”